Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).
7 uur geleden
A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma
8 uur geleden
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia
15 dagen geleden